Tocopherol is a Novel Treatment for Cancer Related Mucositis

Inclusion Criteria

• •Males and non-pregnant and non-lactating females, 18 years of age or older at the time of screening, who are to receive myeloablative agonists with or without total body irradiation (TBI) in preparation for either allogeneic or autologous HSCT. Patients who are to be hospitalized and are expected to remain hospitalized until marrow recovery.
• •Karnofsky performance status of 60 or greater or ECOG performance status of 2 or less.
• •Normal dental examination as assessed by the investigator.